Mckesson (MCK) Cost of Revenue (2009 - 2026)

Mckesson (MCK) reported Cost of Revenue of $92.3 billion for Q1 2026, up 5.81% year-over-year from $87.2 billion in Q1 2025, and down 9.98% quarter-over-quarter from $102.5 billion in Q4 2025.

Mckesson (MCK) Cost of Revenue (2009 - 2026) Analysis & Trends

Mckesson (MCK) has 18 years of Cost of Revenue data on file, last reported at $92.3 billion in Q1 2026.

  • Cost of Revenue for Q1 2026 came in at $92.3 billion, up 5.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $388.9 billion (up 12.48% YoY), and the FY2026 annual result was $388.9 billion, up 12.48% from the prior year.
  • Cost of Revenue declined to $92.3 billion in Q1 2026 per MCK's latest filing, from $102.5 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $102.5 billion in Q4 2025 and troughed at $62.8 billion in Q1 2022.
  • A 5-year average of $79.9 billion and a median of $76.1 billion in 2024 frame the typical range for Cost of Revenue.
  • The sharpest annual moves came in 2022 and 2025: Cost of Revenue rose 3.27% in 2022, then grew 24.19% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $67.3 billion in 2022, then increased by 15.49% to $77.7 billion in 2023, then rose by 18.35% to $92.0 billion in 2024, then increased by 11.37% to $102.5 billion in 2025, then fell by 9.98% to $92.3 billion in 2026.
  • Business Quant data shows MCK's Cost of Revenue at $92.3 billion in Q1 2026, $102.5 billion in Q4 2025, and $99.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 92.25 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 74.77 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 58.44 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 2.30 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 315.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 9.67 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn 379.70 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 19,352.00
10 Cellyan Biotechnology 5.69 -2.48 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 92.25 Bn
Mar 31, 2026 92.25 Bn
Dec 31, 2025 102.47 Bn
Dec 31, 2025 102.47 Bn
Sep 30, 2025 99.61 Bn
Sep 30, 2025 99.61 Bn
Jun 30, 2025 94.55 Bn
Jun 30, 2025 94.55 Bn
Mar 31, 2025 87.18 Bn
Mar 31, 2025 87.18 Bn
Dec 31, 2024 92.01 Bn
Dec 31, 2024 92.01 Bn
Sep 30, 2024 90.40 Bn
Sep 30, 2024 90.40 Bn
Jun 30, 2024 76.13 Bn
Jun 30, 2024 76.13 Bn
Mar 31, 2024 72.77 Bn
Mar 31, 2024 72.77 Bn
Dec 31, 2023 77.75 Bn
Dec 31, 2023 77.75 Bn